Inpharmatis became the winner of the tender for PIL Readability User Testing according to the EAEU requirements for NPO “Microgen”.

This is a mandatory procedure in registering a new medicine or bringing the registration dossier in line with the EAEU requirements. PIL Readability User Testing is conducted to ensure readability, clarity, and ease of comprehension of the information in the package insert. Well-conducted Testing allows the majority of medicine users to make safe and correct decisions.

Requirements for the contents are contained in the Decision of the EEC Council No. 88 and Decision of the EEC Council No. 78.

Inpharmatis has high expertise and proven practical experience in conducting high-quality PIL Readability User Testing in accordance with the requirements of the EAEU. Testing results have been successfully accepted by the regulatory authorities and received 100% approval.